Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients

Diana F Florescu, Donald P. Kotler

Research output: Contribution to journalReview article

49 Citations (Scopus)

Abstract

An increased prevalence of insulin resistance, glucose intolerance and diabetes has been reported in HIV infection in the highly active antiretroviral therapy (HAART) era. This development might be clinically significant because of its association with cardiovascular morbidity and mortality as well as the therapeutic challenges of managing polypharmacy. The development of insulin resistance, glucose intolerance and diabetes could be related to the underlying HIV infection, the contribution of different antiretroviral agents, treatment-associated weight gain, immune restoration, as well as the non-HIV related factors. Dissecting these factors in clinical practice might be difficult. Clinical studies include short-term treatments in healthy, non-HIV-infected individuals; randomized, controlled trials; comparative studies of different HAART regimens; and randomized studies of switching regimens in patients with viral suppression and stable immune function. This article reviews the latest knowledge regarding the epidemiology, pathogenesis, prevention and treatment of insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected individuals.

Original languageEnglish (US)
Pages (from-to)149-162
Number of pages14
JournalAntiviral Therapy
Volume12
Issue number2
StatePublished - Apr 18 2007

Fingerprint

Glucose Intolerance
Insulin Resistance
Diabetes Mellitus
HIV
Highly Active Antiretroviral Therapy
HIV Infections
Anti-Retroviral Agents
Polypharmacy
Therapeutics
Weight Gain
Epidemiology
Randomized Controlled Trials
Morbidity
Mortality

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients. / Florescu, Diana F; Kotler, Donald P.

In: Antiviral Therapy, Vol. 12, No. 2, 18.04.2007, p. 149-162.

Research output: Contribution to journalReview article

@article{1a32942bc6c34b609a4b31a651415d97,
title = "Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients",
abstract = "An increased prevalence of insulin resistance, glucose intolerance and diabetes has been reported in HIV infection in the highly active antiretroviral therapy (HAART) era. This development might be clinically significant because of its association with cardiovascular morbidity and mortality as well as the therapeutic challenges of managing polypharmacy. The development of insulin resistance, glucose intolerance and diabetes could be related to the underlying HIV infection, the contribution of different antiretroviral agents, treatment-associated weight gain, immune restoration, as well as the non-HIV related factors. Dissecting these factors in clinical practice might be difficult. Clinical studies include short-term treatments in healthy, non-HIV-infected individuals; randomized, controlled trials; comparative studies of different HAART regimens; and randomized studies of switching regimens in patients with viral suppression and stable immune function. This article reviews the latest knowledge regarding the epidemiology, pathogenesis, prevention and treatment of insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected individuals.",
author = "Florescu, {Diana F} and Kotler, {Donald P.}",
year = "2007",
month = "4",
day = "18",
language = "English (US)",
volume = "12",
pages = "149--162",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "2",

}

TY - JOUR

T1 - Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients

AU - Florescu, Diana F

AU - Kotler, Donald P.

PY - 2007/4/18

Y1 - 2007/4/18

N2 - An increased prevalence of insulin resistance, glucose intolerance and diabetes has been reported in HIV infection in the highly active antiretroviral therapy (HAART) era. This development might be clinically significant because of its association with cardiovascular morbidity and mortality as well as the therapeutic challenges of managing polypharmacy. The development of insulin resistance, glucose intolerance and diabetes could be related to the underlying HIV infection, the contribution of different antiretroviral agents, treatment-associated weight gain, immune restoration, as well as the non-HIV related factors. Dissecting these factors in clinical practice might be difficult. Clinical studies include short-term treatments in healthy, non-HIV-infected individuals; randomized, controlled trials; comparative studies of different HAART regimens; and randomized studies of switching regimens in patients with viral suppression and stable immune function. This article reviews the latest knowledge regarding the epidemiology, pathogenesis, prevention and treatment of insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected individuals.

AB - An increased prevalence of insulin resistance, glucose intolerance and diabetes has been reported in HIV infection in the highly active antiretroviral therapy (HAART) era. This development might be clinically significant because of its association with cardiovascular morbidity and mortality as well as the therapeutic challenges of managing polypharmacy. The development of insulin resistance, glucose intolerance and diabetes could be related to the underlying HIV infection, the contribution of different antiretroviral agents, treatment-associated weight gain, immune restoration, as well as the non-HIV related factors. Dissecting these factors in clinical practice might be difficult. Clinical studies include short-term treatments in healthy, non-HIV-infected individuals; randomized, controlled trials; comparative studies of different HAART regimens; and randomized studies of switching regimens in patients with viral suppression and stable immune function. This article reviews the latest knowledge regarding the epidemiology, pathogenesis, prevention and treatment of insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected individuals.

UR - http://www.scopus.com/inward/record.url?scp=34147183829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147183829&partnerID=8YFLogxK

M3 - Review article

C2 - 17503657

AN - SCOPUS:34147183829

VL - 12

SP - 149

EP - 162

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 2

ER -